Drug Index

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Generic: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Review priority: STANDARD Marketing status: None (Tentative Approval)

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 05 Sept 2017, 12:00 am (UTC)

Structured Monograph

Approval overview EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE is listed in Drugs@FDA under application 091593 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Form and strength TABLET; ORAL - 200MG Sponsor CIPLA LIMITED Submission history Latest submission status date: 2017-09-05 00:00:00. Submission type: SUPPL.